Some synthetic biologists are building their own brand of open-source science in an effort to enable synthetic biology's potential. Will this open source movement succeed? What level of IP protection is needed?
The safety of early applications of synthetic biology may be adequately addressed by the existing regulatory framework for biotechnology, but further advances in this emerging field are likely to create significant challenges for U.S. government oversight, according to a new report.
Recent action in Congress to reauthorize the U.S. federal nanotechnology research program offers the chance to address the social and ethical issues concerning the emerging scientific field, experts say. A newly released report emphasizes ways in which these topics intersect with governmental functions and responsibilities.
The Synthetic Biology Project is being launched to identify gaps in our knowledge of the potential risks of the field, explore public perceptions towards it, and examine governance options that will both ensure public safety and facilitate innovation. Take the quiz! Winners Announced!
Synthetic biology is being touted by scientists and venture capitalists as “the next big thing.” Researchers claim to be on the brink of creating artificial life in a laboratory and making the world’s first synthetic microbes. But will the promises and pitfalls of synthetic biology catch governments, ethicists, experts, and the public by surprise?
Tracking the last five years of media coverage